The Value Signal — October 29, 2026

731 articles scanned · 6 high-signal

Signal Map

Executive Summary

Across Medicare Advantage, Medicaid, the ACA exchanges and specialty payment, the industry is fighting CMS's timelines and metrics in court and in comment letters while repricing risk on the fly.

Payer Margins and Star Ratings are now as much a litigation strategy as a quality exercise. Healthcare Dive reports that CVS has become at least the fifth insurer to sue over its Medicare Advantage star ratings, alleging a $2 billion hit, while Centene, buoyed by a strong third quarter and the elimination of 6,000 jobs, now expects its Medicare business to break even a year ahead of plan. On Risk Pools, Wakely finds that ACA individual market enrollment fell 15.7% year over year through July 2026 while normalized relative risk rose 6.9%, suggesting healthier members are leaving faster than sicker ones. Exchange carriers should expect pressure on HCC-driven transfers and 2027 rate filings.

Medicaid Work Requirements are moving toward a contested rollout. According to Modern Healthcare, CMS is giving states more flexibility on implementation, even as Becker's Behavioral Health reports that the AMA has joined a legal challenge to the rules ahead of their 2027 start. On the Ambulatory Specialty Model, Premier and six national healthcare organizations have urged CMS to delay the mandatory program, citing unresolved operational and technical challenges. That push signals that specialist readiness, not policy intent, may set the pace of downside-risk expansion.